Antitumor activity of a nitrosourea derivative, CNUA, on murine tumors

1984 ◽  
Vol 13 (1) ◽  
pp. 22-26 ◽  
Author(s):  
Ken-ichi Edanami ◽  
Kanki Komiyama ◽  
Toshio Kuroda ◽  
Iwao Umezawa
1997 ◽  
Vol 4 (6) ◽  
pp. 305-306
Author(s):  
Weiping Liu ◽  
Huizhou Xiong ◽  
Yikun Yang ◽  
Ling Li ◽  
Zhiqiang Shen ◽  
...  

Antitumor activity of the adduct between Carboplatin and α-cyclodextrin has been tested against Sarcoma 180 (S180) and Ehrlich ascites carcinoma (EAC) murine tumors. The preliminary toxicity has also been evaluated by histological examinations of the treated animals. The results show the adduct has less antitumor efficacy than and similar toxicity to Carboplatin.


1987 ◽  
Vol 40 (12) ◽  
pp. 1768-1772 ◽  
Author(s):  
KANKI KOMIYAMA ◽  
YUMIKO HIROKAWA ◽  
HIROKO YAMAGUCHI ◽  
SHINJI FUNAYAMA ◽  
KAZUAKI MASUDA ◽  
...  

1987 ◽  
Vol 10 (3) ◽  
pp. 148-151 ◽  
Author(s):  
TAKEHIKO KUNIMOTO ◽  
KAZUO NITTA ◽  
TOMIKO TANAKA ◽  
NOBUAKI UEHARA ◽  
HIROYASU BABA ◽  
...  

1991 ◽  
Vol 28 (5) ◽  
pp. 351-356 ◽  
Author(s):  
Tsunetaka Nakajima ◽  
Hirotoshi Masuda ◽  
Tadao Okamoto ◽  
Masahiro Watanabe ◽  
Kazumasa Yokoyama ◽  
...  

2017 ◽  
Vol 16 (4) ◽  
pp. 55-60 ◽  
Author(s):  
N. S. Saprykina ◽  
L. M. Borisova ◽  
M. P. Kiseleva ◽  
V. P. Krasnov ◽  
G. L. Levit ◽  
...  

Background. Drugs of nitrosourea class are actively and successfully administered in oncology practice. However, at present, the search for new antitumor agents of this class is very urgent. Objective: to examine in vivo antitumor activity of ormustine, a new Russian drug from alkylnitrosourea class, against solid transplantable murine tumors: melanoma B16 and epidermoid Lewis lung carcinoma. Materials and methods. The assessment of antitumor activity of ormustine and a reference drug mustophoran (Les Labolatories Servier, France) was carried out in B6D2F1 mice. Ormustine was administered intravenously at a single dose of 50-135 mg/kg. Mustophoran was administered intravenously at a dose of 32 mg/kg twice (on days 2 and 9) and 3 times at a dose of 25 mg/kg (on days 2, 6 and 9). The follow-up period lasted till the death of animals. The antitumor effect of agents was assessed by the tumor growth inhibition and increase in life span of experimental mice compared to control animals. Results. It has been defined that the single intravenous dose of ormustine (125 mg/kg) is therapeutic for mice bearing melanoma B16 and epidermoid Lewis lung carcinoma. Conclusions. Ormustine possesses high antitumor effect against solid transplantable murine tumors. Ormustine is not inferior to mustophoran in the therapeutic effect against melanoma B16.


1993 ◽  
Vol 16 (8) ◽  
pp. 778-781 ◽  
Author(s):  
Masahiko HAYASHI ◽  
Hiromichi ITOH ◽  
Takehiko KOSHIO ◽  
Keiji NAKAGAMI ◽  
Kanki KOMIYAMA

2004 ◽  
Vol 171 (4S) ◽  
pp. 188-189
Author(s):  
Aaron T. Ludwig ◽  
Jill M. Moore ◽  
Yi Luo ◽  
Xiaohong Chen ◽  
Michael A. O’Donnell ◽  
...  
Keyword(s):  

2017 ◽  
Author(s):  
P Sartorelli ◽  
A Santos ◽  
C Figueiredo ◽  
J Lago ◽  
M Soares
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document